Effect of lamotrigine and carbamazepine on corticotropin-releasing factor-associated serotonergic transmission in rat dorsal raphe nucleus (Q28564629)

1

1 reference

31 January 2017

Satoshi Yamamura

2

1 reference

31 January 2017

Masanori Nakagawa

3

1 reference

31 January 2017

Eishi Motomura

4

1 reference

31 January 2017

Motohiro Okada

https://scigraph.springernature.com/pub.10.1007/s00213-011-2506-y

5

1 reference

31 January 2017

language of work or name

1 reference

1 April 2012

1 reference

31 January 2017

1 reference

31 January 2017

220

1 reference

31 January 2017

3

1 reference

31 January 2017

599–610

1 reference

31 January 2017

0 references

cites work

Effect of acute and chronic lamotrigine on basal and stimulated extracellular 5-hydroxytryptamine and dopamine in the hippocampus of the freely moving rat.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

Effects of acute and chronic lamotrigine treatment on basal and stimulated extracellular amino acids in the hippocampus of freely moving rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

Effects of combined lamotrigine and valproate on basal and stimulated extracellular amino acids and monoamines in the hippocampus of freely moving rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

Lamotrigine, carbamazepine and phenytoin differentially alter extracellular levels of 5-hydroxytryptamine, dopamine and amino acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

The role of corticotropin-releasing factor in depression and anxiety disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

Sensitivity to stress: dysregulation of CRF pathways and disease development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

A 6-week randomized, placebo-controlled trial of CP-316,311 (a selective CRH1 antagonist) in the treatment of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

Expression cloning of a human corticotropin-releasing-factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

Design and synthesis of a series of non-peptide high-affinity human corticotropin-releasing factor1 receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

Discovery of potent furan piperazine sodium channel blockers for treatment of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

Role of CRF receptor signaling in stress vulnerability, anxiety, and depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

Central CRH system in depression and anxiety--evidence from clinical studies with CRH1 receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

The organization of divergent axonal projections from the midbrain raphe nuclei in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

Differential effects of CRF1 and CRF2 receptor antagonists on pain-related sensitization of neurons in the central nucleus of the amygdala.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

Pro- and anti-nociceptive effects of corticotropin-releasing factor (CRF) in central amygdala neurons are mediated through different receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

Gene expression profiling in postmortem prefrontal cortex of major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

Pharmacological discrimination between effects of carbamazepine on hippocampal basal, Ca(2+)- and K(+)-evoked serotonin release

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

The highly selective CRF(2) receptor antagonist K41498 binds to presynaptic CRF(2) receptors in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

Relationships Between Plasma Concentrations of Diphenylhydantoin, Phenobarbital, Carbamazepine, and 3-Sulfamoylmethyl-1,2-Benzisoxazole (AD-810), a New Anticonvulsant Agent, and Their Anticonvulsant or Neurotoxic Effects in Experimental Animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

Lamotrigine has an anxiolytic-like profile in the rat conditioned emotional response test of anxiety: a potential role for sodium channels?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

Lamotrigine and therapeutic drug monitoring: retrospective survey following the introduction of a routine service

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

Getting closer to affective disorders: the role of CRH receptor systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

Determination of effects of antiepileptic drugs on SNAREs-mediated hippocampal monoamine release using in vivo microdialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

Biphasic effects of carbamazepine on the dopaminergic system in rat striatum and hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

Effects of carbamazepine on hippocampal serotonergic system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

Effects of Ca2+ channel antagonists on striatal dopamine and DOPA release, studied by in vivo microdialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

Differential effects of adenosine receptor subtypes on release and reuptake of hippocampal serotonin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

Effects of corticotropin-releasing factor on brain serotonergic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

Lamotrigine inhibits monoamine uptake in vitro and modulates 5-hydroxytryptamine uptake in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

Effect of lamotrigine on the activities of monoamine oxidases A and B in vitro and on monoamine disposition in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

Lamotrigine inhibits basal and Na+-stimulated, but not Ca2+-stimulated, release of corticotropin-releasing hormone from the rat hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

Human urocortin II: mild locomotor suppressive and delayed anxiolytic-like effects of a novel corticotropin-releasing factor related peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

Corticotropin-releasing factor in the dorsal raphe nucleus: Linking stress coping and addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

Comparison of serum, cerebrospinal fluid and brain extracellular fluid pharmacokinetics of lamotrigine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

Electrophysiological and pharmacological properties of the human brain type IIA Na+ channel expressed in a stable mammalian cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

Topiramate and zonisamide prevent paradoxical intoxication induced by carbamazepine and phenytoin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

Effects of quetiapine on monoamine, GABA, and glutamate release in rat prefrontal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

Effects of zotepine on extracellular levels of monoamine, GABA and glutamate in rat prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

Zonisamide enhances delta receptor-associated neurotransmitter release in striato-pallidal pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

Effects of zonisamide on neurotransmitter release associated with inositol triphosphate receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

Different actions for acute and chronic administration of mirtazapine on serotonergic transmission associated with raphe nuclei and their innervation cortical regions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

Carbamazepine prevents breakdown of neurotransmitter release induced by hyperactivation of ryanodine receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

Rats harboring S284L Chrna4 mutation show attenuation of synaptic and extrasynaptic GABAergic transmission and exhibit the nocturnal frontal lobe epilepsy phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

Progress in corticotropin-releasing factor-1 antagonist development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2506-Y

A blinded, randomized comparison of immediate-release and extended-release carbamazepine capsules in manic and depressed bipolar subjects.

21 January 2018

1 reference

12 December 2020

Neurobiology of corticotropin releasing factor (CRF) receptors and CRF-binding protein: implications for the treatment of CNS disorders

1 reference

12 December 2020

Microdialysis probes calibration: gradient and tissue dependent changes in no net flux and reverse dialysis methods

1 reference

12 December 2020

Regulation of serotonin release in the lateral septum and striatum by corticotropin-releasing factor.

1 reference

12 December 2020

Different binding modes of amphibian and human corticotropin-releasing factor type 1 and type 2 receptors: evidence for evolutionary differences

1 reference

12 December 2020

Origin and functional role of the extracellular serotonin in the midbrain raphe nuclei

1 reference

12 December 2020

Carbamazepine and 10,11-epoxycarbamazepine produce use- and voltage-dependent limitation of rapidly firing action potentials of mouse central neurons in cell culture.

1 reference

12 December 2020

Lamotrigine: when and where does it act in affective disorders? A systematic review

1 reference

12 December 2020

Guide to Receptors and Channels (GRAC), 4th Edition

1 reference

12 December 2020

Stress system abnormalities in melancholic and atypical depression: molecular, pathophysiological, and therapeutic implications.

1 reference

12 December 2020

Effects of Corticotropin-Releasing Factor on Neuronal Activity in the Serotonergic Dorsal Raphe Nucleus

1 reference

12 December 2020

Localized epileptiform activity induced by murine CRF in rats

1 reference

12 December 2020

New medication treatment options for bipolar disorders

1 reference

12 December 2020